Concepedia

James Dongjoo Ham

JD

Statistics

Publications

7

Citations

396

H-Index

7

Active since

2016

Affiliations

Massachusetts Institute of Technology(Current)

Dana-Farber Cancer Institute

Harvard University

University of Pittsburgh

Carnegie Mellon University

James Dongjoo Ham is an author at Massachusetts Institute of Technology specializing in oncology, cancer immunology, and cancer immunotherapy.

ORCID

Publications per year

2016–2025

7

Publications

7

mSA2 affinity-enhanced biotin-binding CAR T cells for universal tumor targeting

Jason Lohmueller, James Dongjoo Ham, Michael Kvorjak et al. · OncoImmunology · 2017 · 133 citations · Full text

, , +17

Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity against NPM1 mutated acute myeloid leukemia

Han Dong, James Dongjoo Ham, Guangan Hu et al. · Proceedings of the National Academy of Sciences · 2022 · 132 citations · Full text

, , +17

Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential

Jason Lohmueller, Shuji Sato, Lana Popova et al. · Scientific Reports · 2016 · 44 citations · Full text

, , +17

CAR memory–like NK cells targeting the membrane proximal domain of mesothelin demonstrate promising activity in ovarian cancer

Mubin Tarannum, Khanhlinh Dinh, Juliana Vergara et al. · Science Advances · 2024 · 38 citations · Full text

, , +17

Ovarian Cancer Ascites Inhibits Transcriptional Activation of NK Cells Partly through CA125

Christopher C. Fraser, Bin Jia, Guangan Hu et al. · The Journal of Immunology · 2022 · 21 citations · Full text

, , +17

1–5 of 7